Dispatches from Korea

Inside Celltrion: a biosimilar success story built on landfill

By Dan Stanton

29-Aug-2016 - Last updated on 30-Aug-2016 at 12:56 GMT

Biopharma-Reporter visited the 'pioneers of the mAb biosimilar industry'

Ambition, hard work and a focus on quality has made Celltrion the ‘pioneers of the mAb biosimilar industry,’ the firm told Biopharma-Reporter during a tour of its biomanufacturing site in Songdo, Korea.

Biopharma-Reporter visited the 'pioneers of the mAb biosimilar industry'

Related news

Related products

Seed Train Intensification Using High Cell Density Cryopreservation and Specially-designed Expansion Medium

Take the Right Path Upstream with MilliporeSigma | 20-Jul-2020 | Technical / White Paper

Strategies such as process intensification have the potential to create shorter lead times, reduce plant footprint, increase flexibility, and reduce COGs.

A Cost Analysis and Evaluation of Perfused Seed Train Scenarios Through Process Modeling

Take the Right Path Upstream with MilliporeSigma | 20-Jul-2020 | Technical / White Paper

This white paper describes process modeling and compares the process economics of a conventional upstream process versus three perfused seed train alternatives...

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 20-Jan-2020 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

Microaerobic Fermentation of Lactobacillus acidophilus

Eppendorf for Bioprocess – Solutions that grow with you | 01-Oct-2019 | Application Note

We successfully performed microaerobic fermenta¬tion of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural...